SUMMARY
Two major issues are involved in clinical atherosclerosis treatment. First, there are no significant clinical markers for early diagnosis of atherosclerosis. Second, the plaque will not regress once it initiates even if the risk factors are removed. In this paper, the research shows that the hypermethylation level of the microRNA 145 (miR-145) promoter is related to a DNMT1 and TET2 dynamic imbalance. The reduction of miR-145 causes NLRP3
(nucleotide-binding oligomerization domain-like receptor protein 3) inflammasome activation through CD137/NFATc1 signaling. These findings could be a potential target for plaque regression in the future. DNA methylation is one of the most understood epigenetic modifications. In brief, the cytosines in CpG islands (CG-dinucleotide-rich regions) can be converted to 5-methylcytosine (5-mC) catalyzed by DNA methyltransferases (DNMTs) and further combined by methyl-CpG-binding proteins (11) . DNA methylation is a negative regulatory mechanism in cells through gene silencing in eukaryotic genomes. The methylation status is a dynamic process mediated by the methylation system of DNMTs or by a demethylation system such as TET2 (ten-eleven translocation 2) (12). Although still controversial, the demethylation agent 5-aza-2ʹ-deoxycytidine (5-aza) was shown to inhibit atherosclerosis formation (13, 14) . Recent studies have
shown that the expression of miR-145 is also regulated by methylation. Abnormally high methylation of the miR-145 promoter was reported to cause a low expression level of miR-145 (15) (16) (17) .
However, whether the silence of miR-145 in CVD In this paper, we sought to study the methylation status of the miR-145 promoter in atherosclerosis. 
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Polymerase (Vazyme Biotech, Nanjing, China) and cloning the amplified products at the Kpn I/BamH I sites of the p3ÂFLAG-CMV-24 vector to obtain the constructs p3ÂFLAG-NFATc1-3ʹUTR, p3ÂFLAG-NFATc1, p3ÂFLAG-CD137-3ʹUTR, and p3ÂFLAG-CD137. The TET2 or NFATc1 overexpression and small hairpin RNA targeting NFATc1 (sh-NFATc1) or DNMT1
(sh-DNMT1) knockdown sequences were inserted into the pLenti-puro or PLKO.1 vector, respectively, to create an overexpression or knockdown plasmid.
pLenti-NFATc1 and pLenti-TET2 plasmids were constructed using ECOR I/Xba I sites. 293T cells were Zhong et al. Values are mean AE SEM from 3 samples in each group; *p < 0.05. 5-hmC ¼ 5-hydroxymethylcytosine; DNMT ¼ deoxyribonucleic acid methyltransferase; Tet2 ¼ ten-eleven translocation 2; other abbreviations as in Figure 2 . 
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Newman-Keuls post hoc tests (multiple comparisons) using SPSS version 12.0 (SPSS, Chicago, Illinois). Twotailed p < 0.05 was considered significant. Figures 1A and 1B) , and Mac3 staining was used as a marker for inflammation ( Figures 1C and 1D) . As expected, the level of miR-145 gradually decreased with the progression of plaques and inflammation ( Figure 1E ). 
RESULTS
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Zhong et al. was not altered ( Figures 3A and 3B) . The results were also confirmed in VSMCs treated with TNF-a ( Figures 3C and 3D) . Therefore, DNMT1 and TET2
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were investigated further in VSMCs. We also found that TNF-a increased both the expression and activity of DNMT1 while decreasing the levels of TET2 and 5-hmC, which could be alleviated by 5-aza ( Figures 3E to 3H ).
METHYLATION OF miR-145 MEDIATED BY DNMT1
AND TET2. Given that methylation dynamic alteration can be regulated by inflammation through DNMT1 and TET2, these 2 enzymes were either knocked down or overexpressed in subsequent studies. Real-time polymerase chain reaction results
showed that miR-145 expression was increased in the sh-DNMT1 group or pLenti-TET2 group compared with the control group ( Figures 4A and 4B) . MSP was performed to determine the þ129 CpG site methylation status of miR-145, as described previously. The bands of the methylated specific primer were obvious in the sh-con þ TNF-a group or the pLenti-con þ TNF-a group, whereas DNMT1 knockdown or TET2 overexpression led to the appearance of unmethylated specific bands instead of methylated specific bands, which meant demethylation of the þ129 CpG site ( Figure 4C ). The ChIP assay verified that binding of DNMT1 to the miR-145 promoter was increased, whereas the binding ability to TET2 was decreased in the TNF-a group ( Figures 4D and 4E ).
DEMETHYLATION TREATMENT INHIBITED NLRP3
INFLAMMASOME ACTIVATION.
In Figure 1 , we demonstrated that the degree of inflammation is associated with miR-145 expression and methylation.
Given that the NLRP3 inflammasome is one of the most important molecules in inflammatory reactions, we examined whether NLRP3 activation was regu- Figure V) . Thus, we hypothesized that the effect of miR-145 on NLRP3
could be associated with the CD137/NFATc1 pathway.
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Role of miR-145 Promoter Methylation in Plaque Formation mRNA levels of CD137 and NFATc1 were decreased or increased gradually when cells were transfected with the miR-145 mimic or inhibitor, respectively ( Figure 7A) . Moreover, the miR-145 mimic inhibited the CD137 and NFATc1 proteins induced by TNF-a, whereas the miR-145 inhibitor inhibited the effect of 5-aza ( Figure 7B) . To define the target site in the 3ʹUTRs (noncoding regions), we cloned the CD137 or NFATc1 gene, which included the 3ʹUTRs, into a p3ÂFLAG-CMV-24 eukaryotic expression plasmid.
The mimic inhibited the plasmid in the WT group, whereas no changes were observed if the 3ʹUTR was deleted ( Figure 6C) . The dual-luciferase assay showed a similar tendency ( Figure 6D) . Together, these data Atherosclerosis is a chronic inflammatory disease (24) . Unlike tumors, atherosclerosis is not caused by gene mutations. However, the plaques do not regress even after risk factors are removed (25, 26) , which can be explained by epigenetic alterations (27) . Both DNA methylation and miRNA are involved in the development of atherosclerosis. miR-145 is generally considered a protective factor in VSMC phenotype and viability (28) . In the present study, we found that and interferon-g). MSP revealed that the methylation status of the þ129 CpG site can be regulated by inflammatory cytokines.
A positive correlation between DNA methylation and atherosclerotic lesion grade has been established through genome-wide DNA methylation sequencing in human aortas (29) . In mammalian cells, the methylation is catalyzed by DNMTs, which consist of DNMT1, DNMT3a, and DNMT3b. Among these, DNMT3a and DNMT3b mediate de novo DNA methylation, whereas DNMT1 maintains newly synthesized DNA methylation (30) . Unlike the methylation system, the demethylation system was poorly defined. Despite this finding, TET2 was regarded as yanjinchuan@hotmail.com.
